Global Genome Editing/Genome Engineering Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Genome Editing/Genome Engineering Revenue
• 1.4 Market by Type
  • 1.4.1 Global Genome Editing/Genome Engineering Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 CRISPR
  • 1.4.3 TALEN
  • 1.4.4 ZFN
• 1.5 Market by Application
  • 1.5.1 Global Genome Editing/Genome Engineering Market Share by Application: 2020 VS 2026
  • 1.5.2 Cell Line Engineering
  • 1.5.3 Animal Genetic Engineering
  • 1.5.4 Plant Genetic Engineering
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Genome Editing/Genome Engineering Market Perspective (2015-2026)
• 2.2 Global Genome Editing/Genome Engineering Growth Trends by Regions
  • 2.2.1 Genome Editing/Genome Engineering Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Genome Editing/Genome Engineering Historic Market Share by Regions (2015-2020)
  • 2.2.3 Genome Editing/Genome Engineering Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Genome Editing/Genome Engineering Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Genome Editing/Genome Engineering Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Genome Editing/Genome Engineering Players by Market Size
  • 3.1.1 Global Top Genome Editing/Genome Engineering Players by Revenue (2015-2020)
  • 3.1.2 Global Genome Editing/Genome Engineering Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Genome Editing/Genome Engineering Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Genome Editing/Genome Engineering Market Concentration Ratio
  • 3.2.1 Global Genome Editing/Genome Engineering Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Genome Editing/Genome Engineering Revenue in 2019
• 3.3 Genome Editing/Genome Engineering Key Players Head office and Area Served
• 3.4 Key Players Genome Editing/Genome Engineering Product Solution and Service
• 3.5 Date of Enter into Genome Editing/Genome Engineering Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Genome Editing/Genome Engineering Historic Market Size by Type (2015-2020)
• 4.2 Global Genome Editing/Genome Engineering Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Genome Editing/Genome Engineering Market Size by Application (2015-2020)
• 5.2 Global Genome Editing/Genome Engineering Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Genome Editing/Genome Engineering Market Size (2015-2020)
• 6.2 Genome Editing/Genome Engineering Key Players in North America (2019-2020)
• 6.3 North America Genome Editing/Genome Engineering Market Size by Type (2015-2020)
• 6.4 North America Genome Editing/Genome Engineering Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Genome Editing/Genome Engineering Market Size (2015-2020)
• 7.2 Genome Editing/Genome Engineering Key Players in Europe (2019-2020)
• 7.3 Europe Genome Editing/Genome Engineering Market Size by Type (2015-2020)
• 7.4 Europe Genome Editing/Genome Engineering Market Size by Application (2015-2020)

8 China

• 8.1 China Genome Editing/Genome Engineering Market Size (2015-2020)
• 8.2 Genome Editing/Genome Engineering Key Players in China (2019-2020)
• 8.3 China Genome Editing/Genome Engineering Market Size by Type (2015-2020)
• 8.4 China Genome Editing/Genome Engineering Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Genome Editing/Genome Engineering Market Size (2015-2020)
• 9.2 Genome Editing/Genome Engineering Key Players in Japan (2019-2020)
• 9.3 Japan Genome Editing/Genome Engineering Market Size by Type (2015-2020)
• 9.4 Japan Genome Editing/Genome Engineering Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Genome Editing/Genome Engineering Market Size (2015-2020)
• 10.2 Genome Editing/Genome Engineering Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Genome Editing/Genome Engineering Market Size by Type (2015-2020)
• 10.4 Southeast Asia Genome Editing/Genome Engineering Market Size by Application (2015-2020)

11 India

• 11.1 India Genome Editing/Genome Engineering Market Size (2015-2020)
• 11.2 Genome Editing/Genome Engineering Key Players in India (2019-2020)
• 11.3 India Genome Editing/Genome Engineering Market Size by Type (2015-2020)
• 11.4 India Genome Editing/Genome Engineering Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Genome Editing/Genome Engineering Market Size (2015-2020)
• 12.2 Genome Editing/Genome Engineering Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Genome Editing/Genome Engineering Market Size by Type (2015-2020)
• 12.4 Central & South America Genome Editing/Genome Engineering Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Thermo Fisher Scientific
  • 13.1.1 Thermo Fisher Scientific Company Details
  • 13.1.2 Thermo Fisher Scientific Business Overview
  • 13.1.3 Thermo Fisher Scientific Genome Editing/Genome Engineering Introduction
  • 13.1.4 Thermo Fisher Scientific Revenue in Genome Editing/Genome Engineering Business (2015-2020))
  • 13.1.5 Thermo Fisher Scientific Recent Development
• 13.2 Merck
  • 13.2.1 Merck Company Details
  • 13.2.2 Merck Business Overview
  • 13.2.3 Merck Genome Editing/Genome Engineering Introduction
  • 13.2.4 Merck Revenue in Genome Editing/Genome Engineering Business (2015-2020)
  • 13.2.5 Merck Recent Development
• 13.3 Horizon Discovery
  • 13.3.1 Horizon Discovery Company Details
  • 13.3.2 Horizon Discovery Business Overview
  • 13.3.3 Horizon Discovery Genome Editing/Genome Engineering Introduction
  • 13.3.4 Horizon Discovery Revenue in Genome Editing/Genome Engineering Business (2015-2020)
  • 13.3.5 Horizon Discovery Recent Development
• 13.4 Genscript
  • 13.4.1 Genscript Company Details
  • 13.4.2 Genscript Business Overview
  • 13.4.3 Genscript Genome Editing/Genome Engineering Introduction
  • 13.4.4 Genscript Revenue in Genome Editing/Genome Engineering Business (2015-2020)
  • 13.4.5 Genscript Recent Development
• 13.5 Sangamo Biosciences
  • 13.5.1 Sangamo Biosciences Company Details
  • 13.5.2 Sangamo Biosciences Business Overview
  • 13.5.3 Sangamo Biosciences Genome Editing/Genome Engineering Introduction
  • 13.5.4 Sangamo Biosciences Revenue in Genome Editing/Genome Engineering Business (2015-2020)
  • 13.5.5 Sangamo Biosciences Recent Development
• 13.6 Integrated Dna Technologies
  • 13.6.1 Integrated Dna Technologies Company Details
  • 13.6.2 Integrated Dna Technologies Business Overview
  • 13.6.3 Integrated Dna Technologies Genome Editing/Genome Engineering Introduction
  • 13.6.4 Integrated Dna Technologies Revenue in Genome Editing/Genome Engineering Business (2015-2020)
  • 13.6.5 Integrated Dna Technologies Recent Development
• 13.7 Lonza
  • 13.7.1 Lonza Company Details
  • 13.7.2 Lonza Business Overview
  • 13.7.3 Lonza Genome Editing/Genome Engineering Introduction
  • 13.7.4 Lonza Revenue in Genome Editing/Genome Engineering Business (2015-2020)
  • 13.7.5 Lonza Recent Development
• 13.8 New England Biolabs
  • 13.8.1 New England Biolabs Company Details
  • 13.8.2 New England Biolabs Business Overview
  • 13.8.3 New England Biolabs Genome Editing/Genome Engineering Introduction
  • 13.8.4 New England Biolabs Revenue in Genome Editing/Genome Engineering Business (2015-2020)
  • 13.8.5 New England Biolabs Recent Development
• 13.9 Origene Technologies
  • 13.9.1 Origene Technologies Company Details
  • 13.9.2 Origene Technologies Business Overview
  • 13.9.3 Origene Technologies Genome Editing/Genome Engineering Introduction
  • 13.9.4 Origene Technologies Revenue in Genome Editing/Genome Engineering Business (2015-2020)
  • 13.9.5 Origene Technologies Recent Development
• 13.10 Transposagen Biopharmaceuticals
  • 13.10.1 Transposagen Biopharmaceuticals Company Details
  • 13.10.2 Transposagen Biopharmaceuticals Business Overview
  • 13.10.3 Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Introduction
  • 13.10.4 Transposagen Biopharmaceuticals Revenue in Genome Editing/Genome Engineering Business (2015-2020)
  • 13.10.5 Transposagen Biopharmaceuticals Recent Development
• 13.11 Editas Medicine
  • 10.11.1 Editas Medicine Company Details
  • 10.11.2 Editas Medicine Business Overview
  • 10.11.3 Editas Medicine Genome Editing/Genome Engineering Introduction
  • 10.11.4 Editas Medicine Revenue in Genome Editing/Genome Engineering Business (2015-2020)
  • 10.11.5 Editas Medicine Recent Development
• 13.12 Crispr Therapeutics
  • 10.12.1 Crispr Therapeutics Company Details
  • 10.12.2 Crispr Therapeutics Business Overview
  • 10.12.3 Crispr Therapeutics Genome Editing/Genome Engineering Introduction
  • 10.12.4 Crispr Therapeutics Revenue in Genome Editing/Genome Engineering Business (2015-2020)
  • 10.12.5 Crispr Therapeutics Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer